Acer Therapeutics Inc.

About Acer Therapeutics Inc.

Zevra Therapeutics is a purpose-driven company focused on bringing life-changing therapeutics to people living with rare diseases. They aim to address unmet needs through scientific advances and a patient-first perspective.

Products & Services

MIPLYFFA(r):A therapeutic product offered by Zevra Therapeutics for rare diseases.

Specialties

Rare Diseases Therapeutics Development Clinical Trials Patient-Centric Solutions Niemann-Pick Disease Type C Urea Cycle Disorders Vascular Ehlers-Danlos Sleep Disorders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 1000000 MR: - FA: 1,000,000 FAN: 1000000	D: 2023-06-26 FD: 2023-06-26	1 investors
2	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 2675000 MR: - FA: $2.675 million FAN: 2675000	D: 2023-03-22 FD: 2023-03-22	-

Debt Latest

2023-06-26

$1.0M

1 investor (Pro only)

Registered Direct Offering 2023-03-22

$2.7M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News